Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Anti-Cancer Agents in Medicinal Chemistry|July 14, 2023
STAT3 Signaling Axis and Tamoxifen in Breast Cancer: A Promising Target for Treatment ResistanceMohammad Yasin Zamanian, Maryam Golmohammadi, Ali Alalak, et al.
Fundamental & Clinical Pharmacology|July 4, 2023
Targeting autophagy with tamoxifen in breast cancer: From molecular mechanisms to targeted therapyMohammad Yasin Zamanian, Maryam Golmohammadi, Amir Nili-Ahmadabadi, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Concept of Hybrid Drugs and Recent Advancements in Anticancer HybridsAnkit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, et al.
Brain, Behavior, & Immunity - Health|July 23, 2025
Exploring GPR120/FFAR4 pharmacology: Unveiling novel therapeutic avenues through molecular signaling pathways for Alzheimer's disease interventionPriyadharshini Gogu, Jayhind Bharti, Jagat Pal Yadav, et al.
Current Medicinal Chemistry|January 24, 2025
Thymoquinone-loaded Nanosized Ethosomal-based Hydrogels: Their Preparation, Characterization, in Vitro, Ex Vivo, and Antimicrobial Evaluation against Staphylococcus aureusPratibha Pathak, Waleed H Almalki, Nabil K Alruwaili, et al.
RSC Advances|November 4, 2022
Gaussian field-based 3D-QSAR and molecular simulation studies to design potent pyrimidine-sulfonamide hybrids as selective BRAFV600E inhibitorsAnkit Kumar Singh, Jurica Novak, Adarsh Kumar, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry PerspectiveAdarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, et al.
Biochimica Et Biophysica Acta. General Subjects|November 22, 2022
Computational and experimental therapeutic efficacy analysis of andrographolide phospholipid complex self-assembled nanoparticles against Neuro2a cellsAtul Mourya, Purva Pingle, Chanti Katta Babu, et al.
Plos One|February 19, 2013
Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteersSanjay Mehendale, Madhuri Thakar, Seema Sahay, et al.
Pageof 11